Antiviral Drugs - Bahrain | Statista Market Forecast

The projected revenue in the Antiviral Drugs market in Bahrain is expected to reach US$6.32m in 2024.
It is anticipated that the revenue will demonstrate an annual growth rate (CAGR 2024-2029) of 1.77%, leading to a market volume of US$6.89m by 2029.
When compared globally, United States is expected to generate the highest revenue, amounting to US$30.64bn in 2024.
Bahrain is experiencing a surge in demand for antiviral drugs due to the country's proactive approach in combating viral outbreaks.

Definition:
The Antiviral Drugs market includes treatments against viruses and virus-induced conditions, such as human immunodeficiency viruses (HIV), hepatitis B and C viruses (HBV and HCV), and Ebola. Therapies for the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are also included. HIV therapies also encompass highly active antiretroviral therapies (HAART) and post-exposure prophylaxis. In contrast to antibiotics, antivirals do not destroy the virus but rather inhibit its development.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, AbbVie, Merck

HIV
Hepatitis B and hepatitis C
Ebola
COVID-19

Vaccines
Antibiotics
Immunosuppressants
In vitro diagnostics and rapid tests

The demand for antiviral drugs in Bahrain has been increasing steadily over the past few years.

Customer preferences: Bahrain has a high prevalence of infectious diseases, which has led to an increased demand for antiviral drugs. Additionally, with the recent outbreak of COVID-19, the demand for antiviral drugs has surged.

Trends in the market: The antiviral drugs market in Bahrain is expected to grow at a steady rate due to the increasing prevalence of infectious diseases. The market is also expected to be driven by the rising demand for antiviral drugs to treat COVID-19. Additionally, the increasing availability of generic antiviral drugs is expected to further boost the market growth.

Local special circumstances: Bahrain has a high prevalence of infectious diseases such as hepatitis B and C, which has led to an increased demand for antiviral drugs. The government has implemented various initiatives to control the spread of infectious diseases, which has further increased the demand for antiviral drugs.

Underlying macroeconomic factors: Bahrain has a small population and a high GDP per capita, which has led to a high demand for healthcare services. The government has invested heavily in the healthcare sector, which has led to an increase in the availability of healthcare services, including antiviral drugs. Additionally, the government has implemented various initiatives to control the spread of infectious diseases, which has further increased the demand for antiviral drugs.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.